The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • No Criteria Specification was provided in the publication event for the variant classifaction.
  • The Criteria Specification shown below is a best-estimate based on the VCEP, gene, disease, and publication date.

Variant: NM_000018.4(ACADVL):c.1251del (p.Ser418fs)

CA2499224903

1073505 (ClinVar)

Gene: ACADVL (HGNC:37)
Condition: very long chain acyl-CoA dehydrogenase deficiency (MONDO:0008723)
Inheritance Mode: Autosomal recessive inheritance
UUID: ed709b5f-bc3d-4070-a616-dfde5be00520
Approved on: 2022-12-14
Published on: 2022-12-14

HGVS expressions

NM_000018.4:c.1251del
NM_000018.4(ACADVL):c.1251del (p.Ser418fs)
NC_000017.11:g.7223712del
CM000679.2:g.7223712del
NC_000017.10:g.7127031del
CM000679.1:g.7127031del
NC_000017.9:g.7067755del
NG_007975.1:g.8879del
NG_008391.2:g.1339del
NG_033038.1:g.15833del
ENST00000356839.10:c.1251del
ENST00000322910.9:c.*1206del
ENST00000350303.9:c.1185del
ENST00000356839.9:c.1251del
ENST00000542255.6:n.109del
ENST00000543245.6:c.1320del
ENST00000578579.2:n.422del
ENST00000578711.1:n.208del
ENST00000578824.5:n.667del
ENST00000579425.5:n.275del
ENST00000579546.1:n.88del
ENST00000583850.5:n.26del
ENST00000583858.5:n.280del
ENST00000585203.6:n.459del
NM_000018.3:c.1251del
NM_001033859.2:c.1185del
NM_001270447.1:c.1320del
NM_001270448.1:c.1023del
NM_001033859.3:c.1185del
NM_001270447.2:c.1320del
NM_001270448.2:c.1023del
More

Likely Pathogenic

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Insufficient Evidence"
Met criteria codes 2
PVS1 PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
ACADVL VCEP
The c.1251del (p.Ser418fs) also known as (p.Ser418AlafsTer12) variant in ACADVL is a frameshift variant predicted to cause a premature stop codon in biologically-relevant-exon 12/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMIDs 9973285, 11590124). To our knowledge, this variant has not been reported in the literature in any individuals with very long chain acyl-CoA dehydrogenase (VLCAD) deficiency. Additionally, to our knowledge, functional assays have not been reported for this variant. This variant is absent from gnomAD v2.1.1 (PM2_Supporting). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal recessive VLCAD deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PVS1, PM2_Supporting (VCEP specifications version1; approved November 8, 2021)
Met criteria codes
PVS1
The c.1251del (p.Ser418AlafsTer12) variant in ACADVL is a frameshift variant predicted to cause a premature stop codon in biologically-relevant-exon 12/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMIDs 9973285, 11590124).
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_Supporting).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.